State Street’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.83M Buy
168,631
+15,686
+10% +$475K ﹤0.01% 2936
2026
Q1
$4.32M Sell
152,945
-8,554
-5% -$228K ﹤0.01% 3019
2025
Q4
$4.48M Buy
161,499
+18,724
+13% +$451K ﹤0.01% 3040
2025
Q3
$3.56M Buy
142,775
+49,102
+52% +$1.09M ﹤0.01% 3133
2025
Q2
$1.65M Sell
93,673
-111
-0.1% -$1.79K ﹤0.01% 3363
2025
Q1
$1.47M Buy
93,784
+1,778
+2% +$30K ﹤0.01% 3345
2024
Q4
$1.76M Buy
92,006
+38,026
+70% +$783K ﹤0.01% 3358
2024
Q3
$1,000K Buy
+53,980
New +$986K ﹤0.01% 3487

Other funds holding PHVS

State Street's PHVS Position: Q2 2026 in Review

State Street increased its Pharvaris (PHVS) stake by 10% in Q2 2026, buying an estimated $475K and bringing the position to 168,631 shares worth $5.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2936.

State Street first reported a position in PHVS in Q3 2024 and has held it in 8 quarters since. 23 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • State Street held 168,631 shares of Pharvaris worth $5.83M as of Q2 2026.
  • State Street bought 15,686 Pharvaris shares in Q2 2026, an estimated $475K.
  • Pharvaris made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2936 holding.
  • State Street first reported a position in Pharvaris in Q3 2024 and has held it in 8 quarters since.
  • 23 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.